FDA Warns of Risk of Using Cancer Drug for Unapproved Indication

FDA Warns of Risk of Using Cancer Drug for Unapproved Indication

The FDA is reminding both patients and doctors that the cancer drug Keytruda (pembrolizumab) is not approved for use in multiple myeloma after an unusual number of deaths in clinical trials investigating Keytruda in combination with 2 other therapies for the blood cancer.

Two trials examining Keytruda in combination with immunomodulators such as Revlimid (lenalidomide) and Pomalyst (pomalidomide) for multiple myeloma were put on hold in July after investigators reported an “excess” number of deaths in those being treated with Keytruda compared to those in a control arm that did not include the drug. At that time, researchers stopped giving Keytruda to patients in the trials.

“Today’s alert underscores the importance of why new therapies are thoroughly studied to ensure the benefits of taking them outweigh the risks to patients, and we will continue to aggressively monitor clinical trials to ensure patients are protected when safety concerns arise,” Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in a statement.

The FDA also said that if patients are taking Keytruda for approved uses — which include head and neck cancer, Hodgkin lymphoma and melanoma — they should continue taking the medication, as the agency believes the benefits outweigh the risks for these conditions.


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Effects of Vitamin D and Antibiotics during Pregnancy

Effects of Vitamin D and Antibiotics during Pregnancy

A new study out today on Vitamin D and pregnancy plus two more studies on how drugs and supplements given to pregnant women affect the fetus and the offspring for years to come.  Be well.   Bone Density Taking higher doses of Vitamin D during pregnancy showed a correlation with…

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

Belviq, ActiPatch, Free Samples, Dollar Tree Drugs

We knew it was too good to be true – free and cheap drugs aren’t worth it. Also, taking a magic pill to lose weight could give you cancer (!). One ray of sunshine: a pain therapy device using shortwave is now available over-the-counter. Have a lovely Valentine’s Day! Be…

  • Advertisement